US Patent 11497198 Genetically modified mice expressing humanized CD40
Patent 11497198 was granted and assigned to Biocytogen on November, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 23 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
114971980
Date of Patent
November 15, 2022
0Patent Application Number
164354530
Date Filed
June 7, 2019
0Patent Primary Examiner
Edits on 16 Nov, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
Article (+157 characters)
US Patent 11497198 Genetically modified mice expressing humanized CD40
Article
The present disclosure relates to genetically modified non-human animals that express a human or chimeric (e.g., humanized) CD40, and methods of use thereof.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
114971980
Date of Patent
November 15, 2022
0Patent Application Number
164354530
Date Filed
June 7, 2019
0Patent Primary Examiner
Find more entities like US Patent 11497198 Genetically modified mice expressing humanized CD40
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.